Ekso Bionics, Inc.

RICHMOND, CA · CIK 0001552921 · Medtech · Acquired

Exoskeletons for rehabilitation and industrial work that enhance human strength and mobility

eksobionics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$14M
2 Form D · Nov 2013
154 months since last filing
Contracts
$1.5M
2 awards · Veterans Affairs, Defense
#254 of 4531 in medtech
Patents
40
33 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$9,069,222
Private capital raisedForm D · SEC$5,000,000
Federal contractDepartment of Veterans Affairs · Igf::ct::igf Continued Maintenance&repair Of Eksoskeleton Bionic Suits Used For Rehabilitation Purposes$20,000
Federal contractDepartment of Defense · Igf::ot::igf STTR II Contract For Upper Body Exo Skeleton$1,499,979
Federal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
251Fluxion Biosciences Inc.$1.5M—
252PRAEVIUM RESEARCH INC$1.5M—
253SAGE SCIENCE, INC.$1.5M$9.9M
254Ekso Bionics, Inc.$1.5M$14M
255Far UV Technologies Inc$1.5M$1.6M
256TANZEN MEDICAL, INC.$1.5M—
257MICRO-LEADS INC$1.5M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 10 related persons
  • Russ AngoldExecutive Officer · Promoter
  • Scott BanisterDirector
  • Eythor BenderDirector · Executive Officer
  • Michael FawkesDirector
  • Marilyn HamiltonDirector
  • Nathan HardingDirector · Executive Officer · Promoter
  • Amal MooradDirector · Promoter
  • Frank MoremandExecutive Officer
  • Jack PeurachDirector
  • Max Scheder-BieschinExecutive Officer

Patents

USPTO · 33 granted of 40

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.